PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
15590689-9	2005	As a prerequisite for investigating 6-bromo-6-deoxy-L-ascorbic acid transported by SVCTs, SVCT2 transport activity in oocytes was enhanced 14-fold by construction and use of a vector that added a fixed poly(A) tail to the 3" end of cRNA.	6-deoxy-6-bromoascorbic acid	36-67	solute carrier family 23 member 2	Homo sapiens	90-95
15590689-10	2005	For SVCT1 and SVCT2 expressed in oocytes, similar K(m) and V(max) values were observed for ascorbic acid and 6-bromo-6-deoxy-L-ascorbic acid.	6-deoxy-6-bromoascorbic acid	109-140	solute carrier family 23 member 1	Homo sapiens	4-9
15590689-10	2005	For SVCT1 and SVCT2 expressed in oocytes, similar K(m) and V(max) values were observed for ascorbic acid and 6-bromo-6-deoxy-L-ascorbic acid.	6-deoxy-6-bromoascorbic acid	109-140	solute carrier family 23 member 2	Homo sapiens	14-19
15590689-12	2005	Using activated human neutrophils, predicted to have ascorbate accumulation mediated predominantly by DHA and GLUT transporters, 6-bromo-6-deoxy-L-ascorbic acid accumulation was <1% of accumulation when compared with ascorbic acid.	6-deoxy-6-bromoascorbic acid	129-160	solute carrier family 2 member 1	Homo sapiens	110-114